Mariner, LLC Atai Life Sciences N.V. Transaction History

Mariner, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.27 - $2.28 $1,452 - $2,608	-1,144 Reduced 10.05%	10,244 $13,000
Q2 2023 Aug 11, 2023	SELL	$1.44 - $2.19 $4,003 - $6,088	-2,780 Reduced 19.62%	11,388 $19,000
Q1 2023 May 12, 2023	BUY	$1.17 - $2.7 $3,211 - $7,411	2,745 Added 24.03%	14,168 $24,000
Q4 2022 Feb 14, 2023	BUY	$2.38 - $3.55 $27,186 - $40,551	11,423 New	11,423 $30,000

12.7M

9.2K

118K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $206M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.